Sadly, Ford stopped making the Capri in 1986. Society moved on, and the people of that era grew up, voted for Reagan, and went gray. But once again, there is a new Ford Capri in the world.
The Capri has been miraculously resuscitated in EV form. Aside from the name, the 2024 Capri bears little resemblance to its eccentric progenitor. It is now a practical, tall, four-door electric SUV that looks, well, like nearly every other four-door electric SUV out there right now. (Polestar CEO Thomas Ingenlath even took a pop at the Capri’s design in an Instagram story, where he remarked that the Ford’s shape is nearly identical to the Polestar 2.)
There are two versions, one standard and one premium. Both have a “family design” and are available in several bright colors. The interior is roomy, with a spacious trunk for your ice chests and strollers. The car comes with heated seats that can also massage the occupants. The Capri can get up to 180 mph and has a battery that Ford claims can carry you and your brood up to 389 miles.
Here’s the rub: It’s only for sale in Europe for the time being. Pricing (based on what Capris will go for in the UK) starts at $61,000.
Samsung Strike
This week, Samsung held its Unpacked event in Paris, where it announced new foldables, earbuds, and its own health-tracking smart ring.
But one thing the company wasn’t eager to highlight was the ongoing labor strike of more than 6,500 of its unionized workers that kicked off two days before the event. Initially intended to be a three-day strike, the workers’ protest against working conditions and pay disparities has turned into an indefinite strike.
For now, the company has not responded to workers’ demands to meet with union organizers. (Even though the strikers were out there looking objectively rad as hell in matching headbands.) It’s not yet clear how much the strike will affect Samsung’s production or bottom line, but if the movement keeps gathering steam, it might be only a matter of time until it flattens plans for Samsung’s new foldables.
Slim Pickings
Ozempic is the biggest name in medicine right now. A drug known as a GLP-1 agonist, Ozempic has ushered in an era of weight-loss drugs that can be used to treat obesity and diabetes. Naturally, there’s a lot of other demand for it too, and a shortage of Ozempic and drugs like it mean people who can’t get them through normal medical channels are turning to other means. A whole cottage industry of Ozempic clones has arisen, making it remarkably easy for people to get weight loss meds—even if they may not work the same way, and even if you might have to lie to get them.
This week on the Gadget Lab podcast, WIRED writers Kate Knibbs and Emily Mullin join the show to talk about the science and regulatory realities of Ozempic and other weight loss medications.
